The CHOP combination is active as evidenced by the objective response rate of 100% obtained in this study of patients with advanced HD. It is interesting that despite the low CR rate obtained with CHOP, seven of 12 patients are currently free of disease after having received MOPP following tumor-burden reduction with CHOP. Such an observation may warrant a trial of CHOP alternating with MOPP as initial treatment for advanced HD.
|Original language||English (US)|
|Number of pages||2|
|Journal||Cancer Treatment Reports|
|State||Published - Dec 1 1983|
ASJC Scopus subject areas
- Cancer Research